Home › Kidney Cancer (Renal Cell Carcinoma) › California › Newport Beach
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Newport Beach, CA
5 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Newport Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- Hoag Memorial Hospital Presbyterian, Newport Beach
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Other studies in Newport Beach
- Breast Cancer16 studies
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer10 studies
- COPD9 studies
- Ovarian Cancer9 studies
- Endometrial Cancer7 studies
- Lung Cancer7 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Triple-Negative Breast Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.